SG Americas Securities
ABMD

SG Americas Securities’s Abiomed Inc ABMD Stock Holding History

SG Americas Securities’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,000
Closed -$41K – 3651
2020
Q4 		$41K Hold
15,000
– – ﹤0.01% 3162
2020
Q3 		$262K Buy
+15,000
New +$4.32M ﹤0.01% 2006
2017
Q2 		– Sell
-10,000
Closed -$36K – 3621
2017
Q1 		$36K Buy
+10,000
New +$1.16M ﹤0.01% 3144

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SG Americas Securities's ABMD Position: Q4 2022 in Review

SG Americas Securities sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,128 shares — an estimated $523K sold.

SG Americas Securities first reported a position in ABMD in Q3 2013 and held it in 30 quarters. The position peaked at $9.57M in Q2 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • SG Americas Securities reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • SG Americas Securities sold 2,128 Abiomed Inc shares in Q4 2022, an estimated $523K.
  • SG Americas Securities first reported a position in Abiomed Inc in Q3 2013 and held it in 30 quarters.
  • SG Americas Securities's Abiomed Inc position peaked at $9.57M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on SG Americas Securities's 13F filing for Q4 2022, filed 2 Feb 2023.